✦ LIBER ✦

Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer

✍ Scribed by Imjai Chitapanarux; Anun Tonusin; Vimol Sukthomya; Chamita Charuchinda; Nantaka Pukanhapan; Vicharn Lorvidhaya

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Irinotecan and cisplatin as first line c

✍ Chitapanarux, I.; Lorvidhaya, V.; Tonusin, A.; Sukthomya, V.; Charuchinda, C.; P 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Extended phase I study of capecitabine a

✍ Schleucher, N.; Tewes, M.; Achterrath, W.; Cao, S.; Frings, S.; Wilke, H.; Harst 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 364 KB

6576 Irinotecan and low-dose capecitabin

✍ Farhat, F.; Kattan, J.; Chahine, G.; Naser, F.; Youness, F.; Ghosn, M. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Phase II Trial of Weekly Docetaxel/Gemci

✍ Joyce A. O'Shaughnessy; Robert Pluenneke; Jack Sternberg; Pankaj Khandelwal; Des 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 482 KB

A phase II study of docetaxel and cispla

✍ Daniel T.T. Chua; Jonathan S.T. Sham; Gordon K.H. Au 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 110 KB

A clinical phase II study of cisplatin a

✍ A Shamseddine; N Bitar; M Dheiny; A Chehal; Y Abou Mourad; R Jalloul; A Dandashi 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 185 KB